Yu Jialin, Zeng Hongmei
Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Front Nutr. 2025 Aug 21;12:1635844. doi: 10.3389/fnut.2025.1635844. eCollection 2025.
While soy products can potentially affect cognitive function through various mechanisms, the dose-response connection of high soy consumption with major neurocognitive disorder or cognitive impairment remains unclear.
A comprehensive retrieval was performed on PubMed, Embase, Cochrane Library, and Web of Science databases up to September 2024, to identify prospective or cohort studies (without language restrictions) examining the link between high soy consumption and the likelihood of developing major neurocognitive disorder or cognitive impairment. Stata (V15) was employed for data analysis, and a restricted cubic spline (RCS) model was employed for examining the dose-response effect.
Six studies incorporating 68,691 participants were included. Elevated consumption of total soy products was markedly correlated to a reduced likelihood of developing major neurocognitive disorder [odds ratios (OR) = 0.92, 95% confidence intervals (95%CI): 0.84-0.99]. While an association with increased risk of cognitive impairment was observed, it was not statistically significant. The dose-response meta-analysis indicated that a 1-g per day increase in the consumption of soy and natto demonstrated a correlation with an 8 and 14% decrease in the likelihood of developing major neurocognitive disorder, respectively. Subgroup analysis suggested a more pronounced protective effect in individuals not experiencing stroke (OR = 0.66, 95%CI: 0.53-0.82). However, soy consumption showed a paradoxical association with the likelihood of developing cognitive impairment (OR = 1.20, 95%CI: 0.83-1.72). Risk data showed no significant association with cognitive impairment. Dose-response data further explained an inverse relationship between dose and risk of cognitive impairment, with higher doses associated with lower risk.
Elevated consumption of diverse soy products exhibited a linear negative correlation with cognitive decline or major neurocognitive disorder; however, significant heterogeneity remained within both the overall analysis and multiple subgroup analyses.
https://www.crd.york.ac.uk/prospero/, CRD42024508555.
虽然大豆制品可能通过多种机制影响认知功能,但大量食用大豆与主要神经认知障碍或认知损害之间的剂量反应关系仍不明确。
截至2024年9月,对PubMed、Embase、Cochrane图书馆和Web of Science数据库进行全面检索,以识别前瞻性或队列研究(无语言限制),研究大量食用大豆与发生主要神经认知障碍或认知损害可能性之间的联系。使用Stata(V15)进行数据分析,并采用受限立方样条(RCS)模型检验剂量反应效应。
纳入了六项研究,共68,691名参与者。总大豆制品摄入量增加与发生主要神经认知障碍的可能性降低显著相关[比值比(OR)=0.92,95%置信区间(95%CI):0.84-0.99]。虽然观察到与认知损害风险增加有关,但无统计学意义。剂量反应荟萃分析表明,大豆和纳豆摄入量每天增加1克,分别与发生主要神经认知障碍的可能性降低8%和14%相关。亚组分析表明,在未发生中风的个体中保护作用更明显(OR=0.66,95%CI:0.53-0.82)。然而,大豆消费与发生认知损害的可能性呈矛盾关联(OR=1.20,95%CI:0.83-1.72)。风险数据显示与认知损害无显著关联。剂量反应数据进一步解释了剂量与认知损害风险之间的负相关关系,剂量越高风险越低。
多种大豆制品摄入量增加与认知衰退或主要神经认知障碍呈线性负相关;然而,在总体分析和多个亚组分析中均存在显著异质性。